ADPT
Price
$6.39
Change
+$0.39 (+6.50%)
Updated
Dec 20 closing price
58 days until earnings call
PROK
Price
$1.54
Change
+$0.08 (+5.48%)
Updated
Dec 20, 04:59 PM (EDT)
100 days until earnings call
Ad is loading...

ADPT vs PROK

Header iconADPT vs PROK Comparison
Open Charts ADPT vs PROKBanner chart's image
Adaptive Biotechnologies
Price$6.39
Change+$0.39 (+6.50%)
Volume$1.57M
CapitalizationN/A
ProKidney
Price$1.54
Change+$0.08 (+5.48%)
Volume$3.98K
CapitalizationN/A
ADPT vs PROK Comparison Chart
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. PROK commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and PROK is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ADPT: $6.39 vs. PROK: $1.51)
Brand notoriety: ADPT: Notable vs. PROK: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 125% vs. PROK: 297%
Market capitalization -- ADPT: $944.51M vs. PROK: $196.43M
ADPT [@Biotechnology] is valued at $944.51M. PROK’s [@Biotechnology] market capitalization is $196.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, ADPT is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 3 bearish.
  • PROK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ADPT is a better buy in the short-term than PROK.

Price Growth

ADPT (@Biotechnology) experienced а +1.43% price change this week, while PROK (@Biotechnology) price change was -15.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ADPT is expected to report earnings on Feb 18, 2025.

PROK is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($945M) has a higher market cap than PROK($196M). ADPT YTD gains are higher at: 30.408 vs. PROK (-15.169). PROK has higher annual earnings (EBITDA): -131.07M vs. ADPT (-163.5M). PROK has more cash in the bank: 407M vs. ADPT (243M). PROK has less debt than ADPT: PROK (6.44M) vs ADPT (91.8M). ADPT has higher revenues than PROK: ADPT (177M) vs PROK (0).
ADPTPROKADPT / PROK
Capitalization945M196M482%
EBITDA-163.5M-131.07M125%
Gain YTD30.408-15.169-200%
P/E RatioN/AN/A-
Revenue177M0-
Total Cash243M407M60%
Total Debt91.8M6.44M1,426%
TECHNICAL ANALYSIS
Technical Analysis
ADPTPROK
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
58%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 6 days ago
72%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
56%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABRWX17.800.28
+1.60%
DSS AmericaFirstMonthlyRisk-OnRisk-Off I
ETIHX33.680.48
+1.45%
Eventide Healthcare & Life Sciences I
GMYPX16.720.18
+1.09%
Goldman Sachs Large Cap Value P
ODIIX127.571.07
+0.85%
Invesco Discovery R6
JHJCX22.03-1.98
-8.25%
JHancock ESG Large Cap Core C

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+3.42%
RXRX - PROK
37%
Loosely correlated
-0.99%
PRME - PROK
34%
Loosely correlated
+3.94%
BEAM - PROK
33%
Poorly correlated
+8.04%
ADPT - PROK
32%
Poorly correlated
+6.50%
RNA - PROK
32%
Poorly correlated
+2.48%
More